Jean-Claude Mwanza1, Donald L Budenz1, Joshua L Warren2, Aaron D Webel1, Courtney E Reynolds1, Diego T Barbosa3, Shan Lin3. 1. Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina, USA. 2. Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, Connecticut, USA. 3. Department of Ophthalmology, University of California, San Francisco, California, USA.
Abstract
AIM: To estimate the floor of retinal nerve fibre layer (RNFL) thickness measurements and the corresponding retinal sensitivity loss in glaucoma. METHODS: Visual field (VF), Spectralis RNFL (83 patients and 37 healthy subjects) and RTVue RNFL data obtained separately (56 patients and 36 healthy subjects) were reviewed. Global and quadrant residual layer thicknesses and corresponding VF losses were estimated using two Bayesian change point models. RESULTS: The respective residual thicknesses from change point model 1 (CPM1) on Spectralis and RTVue (respectively) were 49.9 and 70.6 µm globally, 57.1 and 83.7 µm superiorly, 55.2 and 79.0 µm inferiorly, 43.1 and 60.5 µm nasally, and 40.1 and 59.5 µm temporally. Corresponding VF losses ranged between -25.1 and -21.7 dB (Spectralis) and between -21.8 and -3.4 dB (RTVue). From CPM2, RNFL thinning reached horizontal asymptotes at VF losses between -18.0 and -10.7 dB (Spectralis) and between -12.1 and -2.5 dB (RTVue). There were no significant differences between postchange point residual layer thicknesses from CPM1 and CPM2 on Spectralis (37.0-50.8 µm vs 38.3-56.0 µm) and RTVue (60.6-80.5 µm vs 58.4-88.8 µm). CONCLUSIONS: Global RNFL thinning reaches the floor at a smaller VF loss level with Spectralis than with RTVue. The nasal and temporal quadrants retain thinner residual layers than superior and inferior quadrant RNFL. Measuring RNFL below their minimums will not yield useful clinical information. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
AIM: To estimate the floor of retinal nerve fibre layer (RNFL) thickness measurements and the corresponding retinal sensitivity loss in glaucoma. METHODS: Visual field (VF), Spectralis RNFL (83 patients and 37 healthy subjects) and RTVue RNFL data obtained separately (56 patients and 36 healthy subjects) were reviewed. Global and quadrant residual layer thicknesses and corresponding VF losses were estimated using two Bayesian change point models. RESULTS: The respective residual thicknesses from change point model 1 (CPM1) on Spectralis and RTVue (respectively) were 49.9 and 70.6 µm globally, 57.1 and 83.7 µm superiorly, 55.2 and 79.0 µm inferiorly, 43.1 and 60.5 µm nasally, and 40.1 and 59.5 µm temporally. Corresponding VF losses ranged between -25.1 and -21.7 dB (Spectralis) and between -21.8 and -3.4 dB (RTVue). From CPM2, RNFL thinning reached horizontal asymptotes at VF losses between -18.0 and -10.7 dB (Spectralis) and between -12.1 and -2.5 dB (RTVue). There were no significant differences between postchange point residual layer thicknesses from CPM1 and CPM2 on Spectralis (37.0-50.8 µm vs 38.3-56.0 µm) and RTVue (60.6-80.5 µm vs 58.4-88.8 µm). CONCLUSIONS: Global RNFL thinning reaches the floor at a smaller VF loss level with Spectralis than with RTVue. The nasal and temporal quadrants retain thinner residual layers than superior and inferior quadrant RNFL. Measuring RNFL below their minimums will not yield useful clinical information. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Ronald S Harwerth; Abhiram S Vilupuru; Nalini V Rangaswamy; Earl L Smith Journal: Invest Ophthalmol Vis Sci Date: 2007-02 Impact factor: 4.799
Authors: Jean-Claude Mwanza; Hanna Y Kim; Donald L Budenz; Joshua L Warren; Michael Margolis; Scott D Lawrence; Pooja D Jani; Garrett S Thompson; Richard K Lee Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Sasan Moghimi; Christopher Bowd; Linda M Zangwill; Rafaella C Penteado; Kyle Hasenstab; Huiyuan Hou; Elham Ghahari; Patricia Isabel C Manalastas; James Proudfoot; Robert N Weinreb Journal: Ophthalmology Date: 2019-03-08 Impact factor: 12.079
Authors: Jithin Yohannan; Michael Cheng; Joseph Da; Sagar Chapagain; Ayodeji Sotimehin; Luke W Bonham; Aleksandra Mihailovic; Michael Boland; Pradeep Ramulu Journal: Ophthalmology Date: 2019-08-29 Impact factor: 12.079
Authors: Elham Ghahari; Christopher Bowd; Linda M Zangwill; James Proudfoot; Kyle A Hasenstab; Huiyuan Hou; Rafaella C Penteado; Patricia Isabel C Manalastas; Sasan Moghimi; Takuhei Shoji; Mark Christopher; Adeleh Yarmohammadi; Robert N Weinreb Journal: Am J Ophthalmol Date: 2019-03-14 Impact factor: 5.258
Authors: Xinbo Zhang; Anna Dastiridou; Brian A Francis; Ou Tan; Rohit Varma; David S Greenfield; Joel S Schuman; David Huang Journal: Am J Ophthalmol Date: 2017-09-28 Impact factor: 5.258